H.R. 5582 119th Congress
Patients Deserve Price Tags Act
Latest action, Sep 26, 2025: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
How the House voted
The House hasn't taken a roll call on this bill in the Congresses covered.
12 cosponsors
Sponsored by John James (Republican). Cosponsors by party, House members included:
- Democrats
- Republicans
- Independents
- Democrat
- Republican
- Independent
Referred to: House: Education and Workforce Committee; House: Energy and Commerce Committee; House: Ways and Means Committee
Who lobbied on it
Clients whose quarterly lobbying reports named it, each quarter.
The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.
The top 25 of 54 clients, by reports
| Client | Lobbying firm | Reports | Reports totaling | From | To | House |
|---|---|---|---|---|---|---|
| COLLEGE OF AMERICAN PATHOLOGISTS | 5 | $968K | Q4 2025 | Q3 2026 | yes | |
| AMERICAN HOSPITAL ASSOCIATION | 4 | $21.0M | Q4 2025 | Q3 2026 | yes | |
| LABORATORY CORPORATION OF AMERICA HOLDINGS | 4 | $1.7M | Q4 2025 | Q3 2026 | yes | |
| NATIONWIDE CHILDREN'S HOSPITAL INC | 4 | $407K | Q4 2025 | Q3 2026 | yes | |
| NOMI HEALTH, INC. | 4 | $360K | Q4 2025 | Q3 2026 | yes | |
| PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | 4 | $12.4M | Q3 2025 | Q3 2026 | yes | |
| PURCHASER BUSINESS GROUP ON HEALTH (PBGH) | ERNST & YOUNG LLP (WASHINGTON COUNCIL ERNST & YOUNG) | 4 | $80K | Q4 2025 | Q3 2026 | yes |
| QUEST DIAGNOSTICS INCORPORATED | 4 | $1.8M | Q4 2025 | Q3 2026 | yes | |
| AMERICAN CLINICAL LABORATORY ASSN | 3 | $2.4M | Q1 2026 | Q3 2026 | yes | |
| BOEING COMPANY | 3 | $7.9M | Q1 2026 | Q3 2026 | yes | |
| CIGNA CORPORATION AND SUBSIDIARIES | TIBER CREEK GROUP | 3 | $270K | Q1 2026 | Q3 2026 | yes |
| CLARITEV (FORMERLY MULTIPLAN CORPORATION) | 3 | $390K | Q1 2026 | Q3 2026 | yes | |
| ELEVANCE HEALTH, INC. | 3 | $5.4M | Q1 2026 | Q3 2026 | yes | |
| INDEPENDENT INSURANCE AGENTS & BROKERS OF AMERICA | 3 | $670K | Q1 2026 | Q3 2026 | yes | |
| NATIONAL BEER WHOLESALERS ASSOCIATION | 3 | $1.1M | Q1 2026 | Q3 2026 | yes | |
| NFIB (NATIONAL FEDERATION OF INDEPENDENT BUSINESS) | 3 | $4.9M | Q1 2026 | Q3 2026 | yes | |
| AMBULATORY SURGERY CENTER ASSOCIATION | THE MCMANUS GROUP | 2 | $0 | Q2 2026 | Q3 2026 | yes |
| AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) | 2 | $6.0M | Q2 2026 | Q3 2026 | yes | |
| AMERICAN BENEFITS COUNCIL | 2 | $550K | Q2 2026 | Q3 2026 | yes | |
| AMERICAN DENTAL ASSOCIATION | 2 | $1.3M | Q2 2026 | Q3 2026 | yes | |
| AMERICAN HOSPITAL ASSOCIATION | THE NICKLES GROUP, LLC | 2 | $0 | Q2 2026 | Q3 2026 | yes |
| AMERICAN SOCIETY FOR NUCLEAR CARDIOLOGY | SUMMIT HEALTH CARE CONSULTING | 2 | $45K | Q2 2026 | Q3 2026 | yes |
| ASSOCIATION OF AMERICAN MEDICAL COLLEGES | 2 | $1.3M | Q2 2026 | Q3 2026 | yes | |
| BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) | 2 | $710K | Q2 2026 | Q3 2026 | yes | |
| BLUE CROSS BLUE SHIELD ASSOCIATION | AVENUE SOLUTIONS | 2 | $0 | Q2 2026 | Q3 2026 | yes |